Short Term Trading Week Starting: 16 Sep, page-7

STTCOMP PAA FA LONG

First of all apologies if this has already been tipped

Imo I believe PAA is still very much under the radar and recent buying has been long term SHs topping up/re-entering as phase 2 trials are about to start imminently.

(1) Phase 2 trials to start imminently
(2) 28 day trial with update I believe from the Co midway
(3) Animal Pharma Giant, ELANCO waiting to exercise commercial agreement pending results
(4) Human trials to be "fast-tracked" with possibly another agreement with another Pharma pending positive phase 2 results

Rather than ramble on, I have attached research paper from JP Equity and Partners, for those who are interested see you on the local threads

disclaimer - I am not paid by JP Equity and Partners or the Co. I am just a shareholder